While these findings are promising, the complexity of human neurodegenerative diseases and the limitations of animal models necessitate cautious interpretation pending clinical validation
they need better ways to access them
These compounds have been shown to support metabolic health by stimulating GLP-1 secretion
This includes selecting the right medication, like our Semaglutide or Tirzepatide programs, determining the appropriate dosage, and providing you with a clear roadmap for your journey
That said, dedicated studies examining CJC-1295 specifically for injury healing are limited
The global GLP-1 market is estimated to grow from USD 49.3 billion in the current year to USD 157.5 billion by 2035, at a CAGR of 11.1% during the forecast period, till 2035